background
human
bocaviru
hbov
newli
discov
parvoviru
increas
evid
avail
support
role
etiolog
agent
lower
respiratori
tract
infect
lrti
object
studi
assess
impact
hbov
viral
load
clinic
characterist
children
hbov
posit
suffer
sever
lrti
method
lower
respiratori
tract
aspir
hospit
children
sever
lrti
obtain
bronchoscopi
hbov
detect
realtim
pcr
infecti
agent
examin
use
pcr
andor
direct
fluoresc
assay
result
thirtyon
patient
test
posit
hbov
respiratori
tract
aspir
fifteen
sampl
high
viral
load
copiesml
sixteen
sampl
low
viral
load
copiesml
durat
present
wheez
hospit
longer
children
high
viral
load
hbov
children
low
viral
load
day
wheez
show
correl
viral
load
hbov
conclus
confirm
hbov
frequent
detect
patient
sever
lrti
wheez
one
common
symptom
present
patient
posit
hbov
high
hbov
viral
load
could
etiolog
agent
lrti
led
sever
lower
respiratori
tract
symptom
longer
durat
wheez
hospit
human
bocaviru
hbov
newli
discov
parvoviru
first
identifi
sweden
pool
nasopharyng
aspir
specimen
largescal
molecular
viru
screen
increas
evid
emerg
support
role
etiolog
agent
lower
respiratori
tract
infect
lrti
hbov
frequent
detect
patient
acut
respiratori
tract
infect
includ
wheez
croup
cough
rhinorrhea
fever
number
epidemiolog
clinic
investig
conduct
assess
hbovrel
ill
clinic
featur
report
resembl
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
infect
frequent
clinic
diagnos
associ
respiratori
hbov
gener
upper
respiratori
tract
infect
bronchiol
pneumonia
bronchiti
asthma
exacerb
nevertheless
data
avail
relat
physic
characterist
clinic
sever
children
hbovposit
lrti
studi
aim
assess
relationship
hbov
viral
load
respiratori
tract
clinic
characterist
achiev
goal
conduct
studi
compar
clinic
characterist
cytokinechemokin
data
respiratori
tract
aspir
two
group
children
hbov
infect
either
high
low
viral
load
studi
popul
hospit
depart
respiratori
medicin
children
hospit
chongq
medic
univers
underw
bronchoscopi
studi
conduct
april
march
total
sequenti
respiratori
tract
aspir
sampl
collect
inform
consent
properli
obtain
patient
guardian
inform
consent
written
sign
guardian
bronchoscopi
studi
approv
ethic
committe
chongq
medic
univers
admiss
medic
histori
physic
examin
children
properli
obtain
record
systemat
studi
defin
lrti
follow
characterist
presenc
wheez
crackl
rale
dyspnea
andor
obstruct
airway
without
fever
presenc
upper
airway
symptom
character
rhinorrhea
bronchit
cough
patient
suspect
lrti
underw
chest
radiographi
pneumonia
defin
presenc
focal
infiltr
lung
consolid
present
chest
radiographi
respiratori
tract
aspir
collect
aspir
gentli
mix
pasteur
pipett
revolv
evenli
mix
ml
aspir
transfer
anoth
tube
cytokin
analysi
four
volum
dithiothreitol
ad
ml
respiratori
tract
aspir
gentli
mix
pasteur
pipett
votex
second
shook
minut
bench
rocker
suspens
subsequ
filter
mm
nylon
gauz
remov
mucu
debri
without
remov
cell
centrifug
rpm
minut
cell
free
supernat
store
cytokin
assay
cell
pellet
resuspend
viral
antigen
detect
use
direct
fluoresc
assay
inmedi
rest
aspir
store
viru
detect
polymeras
chain
reaction
pcr
assay
nucleic
acid
extract
ml
aspir
use
qiaamp
dna
mini
kit
qiagen
usa
sampl
elut
ml
rnasefre
water
pcr
assay
target
gene
hbov
amplif
reaction
contain
ml
sampl
dna
ml
taqman
univers
pcr
master
mix
pe
appli
biosystem
ml
bovin
serum
albumin
mgml
nmoll
primer
bocaforward
gga
aga
gac
act
ggc
aga
caa
bocarevers
ggg
tgt
tcc
tga
tga
tat
gag
c
nmoll
boca
probe
famctg
cgg
ctc
ctg
ctc
ctg
tga
ttamra
amplif
perform
lightcycl
instrument
roch
follow
set
min
cycl
sec
min
standard
quantif
plasmid
contain
hbov
gene
use
serial
dilut
cover
rang
log
criteria
posit
reaction
defin
cycl
threshold
cycl
fluoresc
count
minimum
genom
viral
load
would
allow
reproduc
quantif
copi
per
reaction
correspond
copiesml
respiratori
tract
aspir
analys
perform
diagnost
laboratori
rigor
measur
implement
prevent
contamin
viral
antigen
analyz
adenoviru
adv
influenza
viru
b
flua
b
parainfluenza
viru
piv
rsv
use
direct
fluoresc
assay
direct
fluoresc
assay
respiratori
virus
screen
id
kit
diagnost
hybrid
germani
pcr
use
detect
adv
revers
transcriptionpcr
use
detect
rhinoviru
rv
rsv
human
coronavirus
hcov
flua
b
piv
hmpv
dna
extract
ml
aspir
use
qiaamp
dna
mini
kit
qiagen
usa
elut
ml
ae
buffer
rna
extract
ml
aspir
use
qiaamp
viru
rna
mini
kit
qiagen
usa
sampl
elut
ml
rnasefre
water
revers
transcript
mg
rna
perform
final
reaction
ml
contain
oligo
dt
primer
pmol
random
buffer
ml
primescript
rt
enzym
mix
takara
japan
amplif
perform
biorad
thermal
cycler
use
commerci
avail
master
mix
promega
usa
standard
protocol
pcr
assay
perform
use
ml
cdnadna
mm
primer
addit
primer
sequenc
pcr
protocol
viral
detect
method
describ
elsewher
unclassifi
rv
identifi
rv
patient
consid
posit
viru
least
one
posit
result
two
method
bacterialyeast
diagnost
sampl
process
immedi
qualit
semiquantit
way
use
standard
microbiolog
method
sampl
macroscop
distinct
coloni
isol
pure
cultur
standard
method
identif
type
sensit
pattern
use
follow
instruct
respiratori
tract
aspir
test
enzym
link
immunosorb
assay
elisa
bd
pharmingen
usa
sampl
measur
duplic
use
varioskan
flash
thermo
follow
manufactur
instruct
concentr
cytokin
determin
interpol
correspond
standard
curv
valu
detect
threshold
minimum
detect
level
assign
data
descript
characterist
patient
analyz
fisher
exact
test
nonparametr
test
median
valu
use
variabl
normal
distribut
cytokinechemokin
concentr
correl
made
spearman
twotail
rank
correl
addit
pearson
linear
regress
twotail
analysi
outcom
relat
variabl
differ
group
consid
statist
signific
spss
version
use
analysi
patient
demograph
clinic
inform
summar
tabl
hbov
dna
detect
pcr
patient
sampl
sampl
also
test
respiratori
virus
includ
rsv
rv
hmpv
flu
hpiv
hcov
adv
among
hbovposit
sampl
sampl
detect
hbov
sampl
one
viru
detect
besid
hbov
notic
common
coinfect
virus
hbov
rsv
children
rv
children
adv
children
hbov
dna
detect
year
round
season
distribut
hbov
note
octob
march
period
januari
march
season
peak
overlap
period
rsv
peak
may
explain
rsv
common
coinfect
viru
hbov
purpos
analysi
patient
divid
two
group
hbov
infect
without
hbov
infect
frequent
respiratori
symptomssign
present
seen
hbovposit
patient
cough
wheez
significantli
high
frequenc
wheez
vs
p
dyspnea
vs
p
note
hbovposit
patient
comparison
hbovneg
patient
tabl
furthermor
signific
differ
note
length
hospit
stay
hbovposit
hbovneg
patient
tabl
gener
clinic
find
sever
patient
hbov
infect
clinic
characterist
children
detect
hbov
without
coinfect
virus
bacteria
shown
tabl
tabl
tabl
two
group
similar
clinic
manifest
durat
hospit
wheez
among
hbovposit
sampl
also
posit
bacteria
signific
differ
found
whether
associ
bacteria
tabl
therefor
find
support
exist
signific
interact
hbov
respiratori
virus
bacteria
find
clearli
suggest
pathogen
potenti
hbov
young
children
lrti
quantit
analysi
hbov
dna
respiratori
aspir
absolut
quantif
dna
qpcr
reveal
hbov
viral
load
hbovposit
patient
vari
broadli
rang
copi
per
ml
sampl
materi
median
valu
figur
median
viral
load
found
patient
sole
hbov
infect
higher
coinfect
respiratori
virus
p
recent
review
suggest
serum
sampl
avail
pcr
probabl
next
best
option
quantit
pcr
cutoff
copiesml
respiratori
tract
secret
sever
previou
studi
report
increas
serum
hbov
igm
igg
found
patient
high
hbov
load
copiesml
respiratori
tract
secret
associ
respiratori
symptom
therefor
hbovposit
sampl
divid
nonoverlap
popul
one
group
sampl
high
viral
load
copiesml
one
group
sampl
low
viral
load
copiesml
high
hbov
viral
load
detect
patient
comparison
demograph
clinic
data
among
patient
shed
high
hbov
copiesml
respiratori
tract
aspir
shed
low
hbov
shown
tabl
hbovposit
patient
distribut
age
gender
differ
two
group
almost
hbovposit
patient
present
cough
wheez
nonspecif
lower
respiratori
tract
symptom
fever
rhinorrhea
signific
correl
hbov
viral
load
howev
symptom
observ
patient
seriou
lrti
like
tachypnea
dyspnea
cyanosi
present
frequent
children
high
hbov
viral
load
mean
cytokinechemokin
concentr
respiratori
tract
aspir
patient
hbov
infect
shown
tabl
patient
high
hbov
viral
load
level
found
higher
low
hbov
viral
load
level
similar
two
group
order
identifi
whether
potenti
coinfect
would
influenc
cytokin
product
biolog
signific
compar
product
patient
hbov
detect
patient
hbov
virus
bacteria
detect
signific
differ
found
tabl
tabl
longer
durat
hospit
day
wheez
found
among
children
high
hbov
load
tabl
look
correl
viral
load
durat
hospit
stay
day
wheez
search
addit
evid
etiolog
studi
whether
viral
load
hbov
unrel
correl
day
hospit
present
wheez
found
day
wheez
show
direct
correl
viral
load
correl
coeffici
p
figur
studi
patient
seriou
lower
respiratori
tract
ill
detect
hbov
respiratori
tract
aspir
confirm
hbov
frequent
detect
children
sever
lrti
wheez
one
common
symptom
present
hbovposit
patient
hbov
high
load
could
etiolog
agent
lrti
led
sever
lower
respiratori
tract
symptom
longer
hospit
longer
durat
wheez
hbov
detect
worldwid
low
hbov
viral
load
usual
frequent
detect
high
hbov
viral
load
children
role
pathogen
respiratori
tract
often
question
howev
hbov
high
load
clearli
suggest
etiolog
agent
respiratori
tract
diseas
studi
fifteen
thirtyon
hbovposit
patient
high
hbov
viral
load
present
acut
primari
infect
symptom
durat
hospit
compar
among
patient
lrti
without
hbov
infect
tabl
clinic
characterist
children
hbov
detect
without
detect
bacteria
clinic
data
hbov
without
bacteria
detect
n
hbov
bacteria
detect
n
p
found
patient
lrti
hbov
infect
need
longer
hospit
stay
find
suggest
hbov
one
common
pathogen
children
seriou
lrti
although
increas
number
studi
suggest
pathogen
potenti
hbov
young
children
respiratori
tract
infect
howev
hbov
frequent
detect
asymptomat
children
respiratori
tract
secret
may
rais
justifi
concern
etiolog
variat
hbov
detect
studi
like
attribut
multipl
factor
patient
age
season
geograph
locat
primer
sensit
laboratori
techniqu
true
variat
incid
hbov
method
use
sampl
collect
studi
suggest
persist
viru
shed
therefor
reason
explan
high
occurr
hbov
healthi
subject
moreov
failur
followup
hbovposit
asymptomat
children
also
led
high
occurr
hbov
detect
asymptomat
children
recent
vitro
studi
hbov
infect
pseudostratifi
epitheli
cell
establish
confirm
viru
uptak
transcript
replic
studi
support
concept
hbov
respiratori
pathogen
agreement
previou
studi
coinfect
pathogen
common
hbovposit
patient
studi
signific
differ
found
term
frequenc
specif
respiratori
symptom
durat
hospit
wheez
cytokin
product
patient
hbov
infect
patient
coinfect
virus
bacteria
clearli
result
indic
potenti
coinfect
influenc
clinic
outcom
hbov
infect
respiratori
tract
find
strongli
suggest
pathogen
potenti
hbov
young
children
lrti
viru
coinfect
would
increas
ill
durat
sever
virusinduc
respiratori
diseas
studi
other
therefor
sever
lower
respiratori
tract
symptom
present
high
hbov
viral
load
patient
may
sole
depend
hbov
viral
load
studi
hbov
viral
load
show
signific
influenc
present
upper
respiratori
tract
infect
symptom
cough
rhinorrhea
howev
high
hbov
viral
load
led
sever
lower
respiratori
tract
symptom
longer
hospit
also
indic
vitro
studi
viral
infect
result
high
level
proinflammatori
molecul
cytokin
like
bring
addit
neutrophil
also
caus
hyperrespons
bronchu
could
contribut
sever
upper
lower
respiratori
symptom
viral
infect
studi
level
significantli
higher
patient
high
hbov
viral
load
low
viral
load
overal
find
indic
high
hbov
viral
load
play
import
role
sever
lrti
symptom
durat
hospit
stay
previou
studi
show
distinct
clinic
sign
help
differenti
hbovposit
infect
viral
infect
studi
main
clinic
symptom
hbovposit
patient
includ
cough
wheez
fever
although
exist
hbov
directli
associ
ill
studi
show
wheez
main
manifest
hbov
infect
data
consist
find
studi
support
fact
wheez
one
common
symptom
present
hbovposit
patient
also
investig
relationship
hbov
viral
load
durat
wheez
found
day
wheez
correl
viral
load
emili
et
al
document
persist
hbov
shed
may
increas
durat
respiratori
symptom
report
may
explain
link
hbov
load
persist
wheez
studi
comprehens
clinic
observ
hbovposit
patient
sever
lrti
failur
followup
one
limit
studi
may
led
loss
import
data
impact
persist
viral
shed
infect
prognosi
acut
viral
infect
also
import
assess
asthma
develop
case
possibl
tabl
cytokinechemokin
concentr
respiratori
tract
aspir
children
hbov
detect
without
detect
bacteria
cytokinechemokin
pgml
hbov
without
bacteria
detect
n
hbov
bacteria
detect
n
p
